Emergent BioSolutions Inc (EBS)

8.10 +0.04 (+0.50%) USD  |  NYSE  |  Dec 20, 16:00
8.12 +0.02 (+0.25%) After-Hours: 20:00
More

Emergent BioSolutions Max Drawdown (5Y): 98.89% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for EBS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Abbott Laboratories 33.88%
Tonix Pharmaceuticals Holding Corp 100.00%
Chimerix Inc 97.79%
Geron Corp 86.09%
MAIA Biotechnology Inc --

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -52.38
Beta (5Y) 1.594
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 105.9%
Historical Sharpe Ratio (5Y) -0.2935
Historical Sortino (5Y) -0.8043
Monthly Value at Risk (VaR) 5% (5Y Lookback) 35.42%